FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
01/07/2026
Back to search
Official data from USPTO
CLIDEX
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
CLIDEX
ST13
US500000079391496Class
10, 42, 44
Filing
79391496
Registration
7971334
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
35
Latest update
04/03/2026
Trademark type
Word
Nice classes
10, 42, 44
Filing date
11/09/2023
Registration date
10/07/2025
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
10/07/2025
Last transaction
04/03/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
4
Owner type
03
Owner location
KR
Examiner
BURDECKI, ANNA C
Law office
L80
Current location
FILE REPOSITORY (FRANCONIA)
Holders and representatives
Holders
Dx & Vx Co., Ltd.
Representatives
James R Menker Holley & Menker, PA
Technical classification
Nice Classes
Class 10Class 42Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 10
In vitro diagnostic devicesmedical imaging apparatusmedical diagnostic apparatus for analyzing and measuring electrolytes in the body; in vitro diagnostic devices for medical purposesmedical test kits for diabetes monitoring for home usedevices for monitoring blood glucose for medical purposesgenetic testing apparatus for medical purposes; medical apparatus and instrumentssurgical apparatus and instruments for medical useoxygen monitors for medical usemedical imaging apparatusmedical drapesmedical endoscopesanesthesia machinesblood pressure measuring apparatusdefibrillators; apparatus for clinical diagnosismedical imaging apparatusultrasound probes for medical useelectrocardiographic (ECG) recordershematology analyzers for medical diagnostic usesclinical thermometers; DNA extraction and purification apparatus for DNA testing for medical purposes; apparatus for use in medical analysisapparatus for blood analysisflow cytometers for medical diagnostic uses; genetic testing apparatus in the nature of apparatus for DNA and RNA testing for medical purposes; diagnostic apparatus for medical purposesmedical imaging apparatusultrasound probes for medical useMRI apparatus for medical purposesX-ray CT scanners; measuring instruments for medical purposesdevices for measuring woundsheartbeat measuring apparatuspulse oximeters for medical purposesblood glucose meters; medical genetic analyzer being apparatus for DNA and RNA testing for medical purposes; biometric measuring devices for medical purposefetal heartbeat monitorswearable wrist monitors used to measure biometric data for medical use; medicine testing apparatusbiological pharmaceutical blood analysis apparatusuntreated multi-drug testing dip cards for drug use testing purposesimmunochemical testing apparatus for medical useeye testing apparatus; cell testing apparatus for medical purposes being apparatus for DNA and RNA testing for medical purposes; telemetry apparatus for medical purposes; orthopedic devices for diagnostic and therapeutic use; medical fluid injectors for medical purposes; apparatus for analyzing substances for medical usebreath gas analyzers for medical diagnosticsapparatus used in implementing diagnosis tests designed to detect the abnormal prion protein; apparatus for the regeneration of stem cells for medical purposes; X-ray apparatus for medical purposes; apparatus for analyzing blood for medical use; syringes for injection of medical substances; medical productsminiaturized biofeedback sensors for use in gene analysis and diagnosis; receptacles for applying medicineshypodermic syringesspacers for inhalerstransdermal drug delivery patches sold without medicationeye drop guides
Class 42
Scientific research in the field of biomedicine; medical research; DNA analysis for scientific research purposes; providing scientific research information relating to scientific analysis of genetic information via online networks; medical and scientific researchconducting clinical trials for others; scientific research in the field of gene analysis; remote monitoring of medical diagnostic devices to ensure proper functioning; product research and development in the field of medical products; medical research laboratories; consultancy in analysis of genomics for medical research purposes; stem cell research services; biological analysisgenetic testing for scientific research purposes in the field of medicine; biological researchgenetic testing for scientific research purposes; product development in the field of devices for biological chemicals analysis; providing information in the fields of medical research; product development of medical devices; medical research laboratory services for predicting disease; scientific research in the field of protein analysis; scientific research in the field of multiple nucleotide sequence analysis; research and development of medical apparatus and instruments for others; scientific research in the field of processing and handling of chemical reagents; medical research services relating to clinical data
Class 44
Medical co-diagnostic services; medical diagnostic services; medical co-diagnostic services for medical purposes; medical testing in the field of molecules for diagnostic purposes; medical and health services relating to DNAgenetics and genetic testing; genetic testing for medical purposes; provision information about genetic testing for medical treatment purposes; provision of medical information; medical analysis services relating toblood testinggenetic testingmicrobiological analysisurine analysisdiagnostic imaging interpretationmolecular diagnosticspathology serviceshormone level testingdrug screeningdisease biomarkers analysis; telemedicine services; medical analysis services relating to the treatment of persons; medical services; medical analysis of human tissues for the purpose of medical treatment of persons; medical examination services; provision of medical services; health clinic services for medical purposes; medical analysis relating to clinical data for medical diagnosis and treatment purposes; providing health care information via electronic means; medical analysis for the diagnosis and treatment of persons; medical information services relating to medical products; medical diagnostictesting and analysis services for medical diagnostic and treatment purposes; health advice being health and information services; medical and pharmaceutical consultation
Publications
History of USPTO decisions and trademark events.
35 publications found
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
10/07/2025
R.PR
REGISTERED-PRINCIPAL REGISTER
10/07/2025
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
10/03/2025
OPNX
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
09/05/2025
LIMG
LIMITATION OF GOODS RECEIVED FROM IB
08/29/2025
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
08/19/2025
PUBO
PUBLISHED FOR OPPOSITION
08/19/2025
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
08/13/2025
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
08/13/2025
OPNR
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
08/13/2025
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
07/09/2025
XAEC
EXAMINER'S AMENDMENT ENTERED
07/09/2025
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
07/09/2025
GNEA
EXAMINERS AMENDMENT E-MAILED
07/09/2025
CNEA
EXAMINERS AMENDMENT -WRITTEN
07/09/2025
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
05/29/2025
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
05/29/2025
ALIE
ASSIGNED TO LIE
05/29/2025
ERSI
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
05/18/2025
GNS3
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
01/08/2025
GNSL
LETTER OF SUSPENSION E-MAILED
01/08/2025
CNSL
SUSPENSION LETTER WRITTEN
01/08/2025
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
01/07/2025
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
01/07/2025
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
01/07/2025
RFNT
REFUSAL PROCESSED BY IB
07/28/2024
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
07/11/2024
RFRR
REFUSAL PROCESSED BY MPU
07/11/2024
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
06/21/2024
CNRT
NON-FINAL ACTION WRITTEN
06/20/2024
DOCK
ASSIGNED TO EXAMINER
06/17/2024
MAFR
APPLICATION FILING RECEIPT MAILED
04/24/2024
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
03/24/2024
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
03/14/2024
Continuous trademark protection
Get notified about every new filing that threatens CLIDEX or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.